News

Clinical-stage company ImmusanT’s therapeutic vaccine candidate Nexvax2 has been granted fast track designation by the US FDA. ImmusanT uses its trademarked Epitope-Specific Immuno-Therapy (ESIT) platform to create its pipeline of peptide-based immunomodulatory vaccine therapies indicated for...

Nuvo Pharmaceuticals has acquired the rights covering more than 20 drugs from fellow Canadian company Aralez Pharmaceuticals. With the deal, announced by Nuvo on Monday, December 31, Nuvo now owns Aralez’s Canadian speciality pharmaceutical business. This...

DuPont Nutrition & Health has released new findings from a clinical study of a synbiotic dietary supplement that gives hope to overweight consumers at risk of health complications. Combining the benefits of a proven probiotic with...

Quotient Sciences, a leading drug development services organization, and Druggability Technologies (DRGT), a specialty pharmaceutical company, announced a collaboration to utilize Quotient’s integrated Translational Pharmaceutics® platform to advance. The development of DRGT-46, a novel, fast-acting formulation...

Informative webinar hosted by CRF Health, a CRF Bracket company, will address how eConsent can be implemented effectively to support patient centricity and improve study outcomes. Clinical research and technology leaders from across the industry will...

The India Pharma Awards, conducted by UBM India, India’s leading B2B exhibitions organizer, concluded the second and final round of jury selection at The Lalit, Mumbai. The Awards follow a two-step judging process that has been...

MedPharm Ltd is pleased to announce that Eugene Ciolfi has joined as its President and Chief Executive Officer. In conjunction with his hiring, he has also been appointed to MedPharm’s Board of Directors. Gene joins MedPharm...